| Juvenile Rheumatoid Arthritis (JRA) |
1 |
1 |
| Child |
0 |
0.93 |
| Psoriatic Arthritis |
0 |
0.88 |
| Spondylitis, Spondylosis, Kyphosis |
0 |
0.62 |
| Arthritis |
0 |
0.54 |
| Rheumatoid Arthritis |
0 |
0.43 |
| Axial spondyloarthritis |
0 |
0.3 |
| Dermatitis |
0 |
0.25 |
| Crohn Disease |
0 |
0.21 |
| Ulcerative Colitis |
0 |
0.17 |
| Adolescent Medicine |
0 |
0.15 |
| Ankylosing Spondylitis |
0 |
0.15 |
| Atopic Dermatitis |
0 |
0.15 |
| Colitis |
0 |
0.15 |
| Inflammatory Bowel Disease |
0 |
0.12 |
| Vasculitis |
0 |
0.12 |
| Thrombus |
0 |
0.11 |
| Systemic Lupus Erythematosus |
0 |
0.1 |
| Alopecia Areata |
0 |
0.08 |
| Blood |
0 |
0.08 |
| Cancer |
0 |
0.08 |
| Drug and Treatment Safety |
0 |
0.08 |
| Giant Cell Arteritis |
0 |
0.08 |
| Lupus |
0 |
0.08 |
| Pharmacokinetics |
0 |
0.08 |
| Plasma |
0 |
0.08 |
| Takayasu Arteritis |
0 |
0.08 |
| Tumor |
0 |
0.08 |
| Virginia |
0 |
0.08 |
| Vitiligo |
0 |
0.08 |
| Alopecia |
0 |
0.06 |
| Hidradenitis Suppurativa |
0 |
0.06 |
| Patient Safety |
0 |
0.06 |
| Skin and Soft Tissue Infection |
0 |
0.06 |
| Thromboembolism |
0 |
0.06 |
| Tuberculosis |
0 |
0.06 |